.Pharmacolibrary.Drugs.S_SensoryOrgans.S01B_AntiinflammatoryAgents.S01BA13_Rimexolone.Rimexolone .Pharmacolibrary.Drugs.S_SensoryOrgans.S01B_AntiinflammatoryAgents.S01BA13_Rimexolone.Rimexolone| name: | Rimexolone | |
| ATC code: | S01BA13 | route: | ophthalmic |
| compartments: | 1 | |
| dosage: | 1 | mg |
| volume of distribution: | 0.05 | L |
| clearance: | 0.05 | L/h |
| other parameters in model implementation | ||
Rimexolone is a synthetic corticosteroid with anti-inflammatory properties, primarily used as an ophthalmic suspension to treat post-operative eye inflammation and anterior uveitis. It is an FDA-approved medication but is now less commonly used due to the availability of alternatives.
No published human pharmacokinetic (PK) data for rimexolone after ophthalmic administration could be identified; parameter estimates below are theoretical or inferred based on class and administration route.